Eric Ng

Eric Ng has an extensive work experience in the healthcare industry. Eric is currently serving as the Senior Medical Director of Safety and Medical Affairs at A2 Biotherapeutics, Inc. Prior to this role, they worked at Amgen for over 10 years, holding various positions such as Combination Product Safety, Medical Director of Maternal and Pediatrics Team, and Global Safety Medical Director. Eric has also worked as an Attending Physician at Valley Presbyterian Hospital, Children's Hospital Los Angeles (CHLA), and Kaiser Permanente. Additionally, Eric has been involved in leadership roles at the American Academy of Pediatrics and the International Children's Advisory Network (iCAN). Eric started their career as a Research Assistant at Genentech and the University of California, San Francisco.

Eric Ng completed their education in the field of medicine. Eric obtained their MD degree from Rush Medical College of Rush University Medical Center, where they studied from 1997 to 2001. Before that, they pursued a Bachelor of Arts (B.A.) degree in Molecular and Cellular Biology - Immunology from the University of California, Berkeley, from 1993 to 1997.

In addition to their formal education, Eric Ng has also obtained several certifications. These include Lean 6 Sigma Yellow Belt, which they obtained in May 2013. Eric is also certified by the American Board of Pediatrics, achieving Pediatric Board Certification in October 2004. Eric Ng is a Fellow of the American Academy of Pediatrics, although the specific details regarding the institution and the year they obtained this certification are not provided.